Ethics Approval and Informed Consent Sample Clauses

Ethics Approval and Informed Consent. An Independent Ethics Committee or its local equivalent (“EC”), established and constituted in accordance with Applicable Law (defined below), approves and oversees the conduct of each Study. Institution will comply with the directives of the EC, as applicable, and will notify Abbott to the extent any such directives vary from the Protocol. Investigator shall obtain from each person enrolling in the Study, prior to the subject’s participation in the Study (a “Study Subject”) a valid written informed consent form (“ICF”) and document it as required by Applicable Law (defined below). The ICF must permit Abbott and its representatives to access, process, obtain copies, transfer and retain Study data. The Institution and the Investigator will comply with the terms of the consent, the 2.1 Schválení etických komisí a informovaný souhlas. Nezávislá etická komise (▇▇▇▇ ▇▇▇ „EK“), zřízená a ustanovená v souladu s příslušnými právními předpisy (definovanými níže), schvaluje jednotlivé Studie a dohlíží na jejich provádění. Zdravotnické zařízení bude plnit související pokyny EK a bude informovat společnost ▇▇▇▇▇▇ v rozsahu, v jakém se tyto pokyny ▇▇▇▇ ▇▇ Protokolu. Zkoušející ▇▇▇▇▇ ▇▇ každé osoby zařazené do Studie, před její účastí ve Studii (▇▇▇▇ ▇▇▇ „Studijní subjekt“) platný formulář písemného informovaného souhlasu (▇▇▇▇ ▇▇▇ „ICF“) a zdokumentuje jej, jak vyžadují platné právní předpisy (definované níže). ICF musí společnosti ▇▇▇▇▇▇ a jejím zástupcům povolit přístup, zpracování, získávání kopií, přenos a uchovávání studijních údajů. Zdravotnické zařízení a Zkoušející lékař budou dodržovat CONFIDENTIAL DŮVĚRNÉ MCSA EMEA MCSA EMEA Protocol, ▇▇▇▇▇▇’▇ instructions, and any guidance provided by the EC. ▇▇▇▇▇▇ declares that for each Study (each SoW) Investigator will be given the ICF for Study Subjects to be enrolled in the Study and the Study Subjects’ written disclaimer form and that the Abbott shall instruct the Investigator on their use. If the Study Subject consents to be enrolled in the Study, Investigator shall always obtain the signed ICF from the Study subject (or the Study Subject’s legal guardian or guardian), before conducting a preliminary examination or baseline tests as part of the Study. Signed ICF shall be kept in Study documentation administered by Investigator. Study Subjects shall also be informed about the fact that for control purposes, the data gathered about them during the Study may be used and presented to relevant bodies of the administration...
View Source
Ethics Approval and Informed Consent. Institution will ensure that an Institutional Review Board and/or an Independent Ethics Committee (collectively, “EC”), established and constituted in accordance with Applicable Law (defined below) approves and oversees the conduct of each Study. Institution will comply with the directives of the EC, as applicable, and will notify Abbott to the extent any such directives vary from the Protocol. Investigator shall obtain from each person enrolling in the Study, prior to the subject’s participation in the Study (a “Study Subject”) a valid written informed consent form (“ICF”) and document it as required by Applicable Law (defined below). The ICF must permit Abbott and its representatives to access, process, obtain copies, transfer and retain Study data. The Institution and the Investigator will comply with the terms of the consent, the Protocol, ▇▇▇▇▇▇’▇ instructions, and any guidance provided by the EC. Institution will notify Abbott as soon as reasonably practicable if the EC withdraws approval for the Study.
View Source

Related to Ethics Approval and Informed Consent

  • Sales Material and Information 4.1. The Company shall furnish, or shall cause to be furnished, to the Fund or its designee, each piece of sales literature or other promotional material in which the Fund or its investment adviser or the Underwriter is named, at least fifteen Business Days prior to its use. No such material shall be used if the Fund or its designee reasonably objects to such use within fifteen Business Days after receipt of such material. 4.2. The Company shall not give any information or make any representations or statements on behalf of the Fund or concerning the Fund in connection with the sale of the Contracts other than the information or representations contained in the registration statement or prospectus for the Fund shares, as such registration statement and prospectus may be amended or supplemented from time to time, or in reports or proxy statements for the Fund, or in sales literature or other promotional material approved by the Fund or its designee or by the Underwriter, except with the permission of the Fund or the Underwriter or the designee of either. 4.3. The Fund, Underwriter, or its designee shall furnish, or shall cause to be furnished, to the Company or its designee, each piece of sales literature or other promotional material in which the Company and/or its separate account(s), is named at least fifteen Business Days prior to its use. No such material shall be used if the Company or its designee reasonably objects to such use within fifteen Business Days after receipt of such material. 4.4. The Fund and the Underwriter shall not give any information or make any representations on behalf of the Company or concerning the Company, each Account, or the Contracts other than the information or representations contained in a registration statement or prospectus for the Contracts, as such registration statement and prospectus may be amended or supplemented from time to time, or in published reports for each Account which are in the public domain or approved by the Company for distribution to Contract owners, or in sales literature or other promotional material approved by the Company or its designee, except with the permission of the Company. 4.5. The Fund will provide to the Company at least one complete copy of all registration statements, prospectuses, Statements of Additional Information, reports, proxy statements, sales literature and other promotional materials, applications for exemptions, requests for no-action letters, and all amendments to any of the above, that relate to the Fund or its shares, contemporaneously with the filing of such document with the Securities and Exchange Commission or other regulatory authorities. 4.6. The Company will provide to the Fund at least one complete copy of all registration statements, prospectuses, Statements of Additional Information, reports, solicitations for voting instructions, sales literature and other promotional materials, applications for exemptions, requests for no action letters, and all amendments to any of the above, that relate to the Contracts or each Account, contemporaneously with the filing of such document with the SEC or other regulatory authorities. 4.7. For purposes of this Article IV, the phrase "sales literature or other promotional material" includes, but is not limited to, any of the following that refer to the Fund or any affiliate of the Fund: advertisements (such as material published, or designed for use in, a newspaper, magazine, or other periodical, radio, television, telephone or tape recording, videotape display, signs or billboards, motion pictures, or other public media), sales literature (i.e., any written communication distributed or made generally available to customers or the public, including brochures, circulars, research reports, market letters, form letters, seminar texts, reprints or excerpts of any other advertisement, sales literature, or published article), educational or training materials or other communications distributed or made generally available to some or all agents or employees, and registration statements, prospectuses, Statements of Additional Information, shareholder reports, and proxy materials.

  • Background Information The Adviser has entered into an Investment Adviser's Agreement with the Fund ("Investment Adviser's Agreement"). Pursuant to the Investment Adviser's Agreement, the Adviser has agreed to render investment advisory and certain other management services to all of the funds of the Fund, and the Fund has agreed to employ the Adviser to render such services and to pay to the Adviser certain fees therefore. The Investment Adviser's Agreement recognizes that the Adviser may enter into agreements with other investment advisers who will serve as fund managers to the funds.

  • Third-Party Agreements and Information Executive represents and warrants that Executive’s employment by the Company does not conflict with any prior employment or consulting agreement or other agreement with any third party, and that Executive will perform Executive’s duties to the Company without violating any such agreement. Executive represents and warrants that Executive does not possess confidential information arising out of prior employment, consulting, or other third party relationships, that would be used in connection with Executive’s employment by the Company, except as expressly authorized by that third party. During Executive’s employment by the Company, Executive will use in the performance of Executive’s duties only information which is generally known and used by persons with training and experience comparable to Executive’s own, common knowledge in the industry, otherwise legally in the public domain, or obtained or developed by the Company or by Executive in the course of Executive’s work for the Company.

  • Access and Information The Company, on the one hand, and Parent and Acquisition Corp., on the other hand, shall each afford to the other and to the other’s accountants, counsel and other representatives full access during normal business hours throughout the period prior to the Effective Time to all of its properties, books, contracts, commitments and records (including but not limited to tax returns) and during such period, each shall furnish promptly to the other all information concerning its business, properties and personnel as such other party may reasonably request, provided that no investigation pursuant to this Section 6.01 shall affect any representations or warranties made herein. Each party shall hold, and shall cause its employees and agents to hold, in confidence all such information (other than such information that (a) is already in such party’s possession or (b) becomes generally available to the public other than as a result of a disclosure by such party or its directors, officers, managers, employees, agents or advisors or (c) becomes available to such party on a non-confidential basis from a source other than a party hereto or its advisors, provided that such source is not known by such party to be bound by a confidentiality agreement with or other obligation of secrecy to a party hereto or another party until such time as such information is otherwise publicly available; provided, however, that (i) any such information may be disclosed to such party’s directors, officers, employees and representatives of such party’s advisors who need to know such information for the purpose of evaluating the transactions contemplated hereby (it being understood that such directors, officers, employees and representatives shall be informed by such party of the confidential nature of such information), (ii) any disclosure of such information may be made as to which the party hereto furnishing such information has consented in writing and (iii) any such information may be disclosed pursuant to a judicial, administrative or governmental order or request; provided, further, that the requested party will promptly so notify the other party so that the other party may seek a protective order or appropriate remedy and/or waive compliance with this Agreement and if such protective order or other remedy is not obtained or the other party waives compliance with this provision, the requested party will furnish only that portion of such information that is legally required and will exercise its best efforts to obtain a protective order or other reliable assurance that confidential treatment will be accorded the information furnished. If this Agreement is terminated, each party will deliver to the other all documents and other materials (including copies) obtained by such party or on its behalf from the other party as a result of this Agreement or in connection herewith, whether so obtained before or after the execution hereof.

  • Reports and Information Contractor shall at such times and in such forms as the City may require furnish the City such periodic reports as it may request pertaining to the work or services undertaken pursuant to this Agreement, the costs and obligations incurred or to be incurred in connection therewith, and any other matters are covered by this Agreement as specified in Exhibit A and Exhibit E.